CN Patent

CN107519159A — 复方组合物

Assigned to AFT Pharmaceuticals Ltd · Expires 2017-12-29 · 8y expired

What this patent protects

一种用于缓解疼痛和/或炎症的静脉内给药组合物，所述组合物包含联合施用给人的布洛芬和对乙酰氨基酚，其中每剂量的所述组合物包含a)约125mg至约150mg布洛芬与约475mg至约525mg对乙酰氨基酚的组合；或b)约275mg至约325mg布洛芬与约975mg至约1025mg对乙酰氨基酚的组合。

USPTO Abstract

一种用于缓解疼痛和/或炎症的静脉内给药组合物，所述组合物包含联合施用给人的布洛芬和对乙酰氨基酚，其中每剂量的所述组合物包含a)约125mg至约150mg布洛芬与约475mg至约525mg对乙酰氨基酚的组合；或b)约275mg至约325mg布洛芬与约975mg至约1025mg对乙酰氨基酚的组合。

Drugs covered by this patent

Patent Metadata

Patent number
CN107519159A
Jurisdiction
CN
Classification
—
Expires
2017-12-29
Drug substance claim
No
Drug product claim
No
Assignee
AFT Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.